Skip to Search
Skip to Navigation
Skip to Main Content
Skip to Footer
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Login
Google Translate
Select language
English
French
Spanish
Login
Username
*
Password
*
Staff Login
×
Google Translate
Select language
English
French
Spanish
Login
Menu
Site Search
Search Options
Resources
Everything
Advanced Search
Uptodate
All
Title Search
Author
Patients & Caregivers
Healthcare Providers
Researchers & Partners
Investors
menu
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Google News
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Sage Therapeutics stock sinks after drug study failed - Investing.com
Biogen, Sage fail midphase essential tremor trial, extending long wait for new option - Fierce Biotech
Biogen, Sage fail midphase essential tremor trial, extending long wait for new option - Fierce Biotech
Biogen and Sage to scrap neurological disorder drug development after trial failure - Reuters
Biogen and Sage to scrap neurological disorder drug development after trial failure - Reuters.com
Biogen and Sage to scrap neurological disorder drug development after trial failure - Reuters.com
Biogen and Sage to scrap neurological disorder drug development after trial failure - Reuters
Sage Therapeutics (SAGE) Scheduled to Post Quarterly Earnings on Wednesday - Defense World
Biogen stock, Sage stock fall on trial setback (NASDAQ:SAGE) - Seeking Alpha
Biogen stock, Sage stock fall on trial setback (NASDAQ:SAGE) - Seeking Alpha
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »
×